Early results following everolimus-eluting bioresorbable vascular scaffold implantation for the treatment of in-stent restenosis

Int J Cardiol. 2014 May 15;173(3):513-4. doi: 10.1016/j.ijcard.2014.03.061. Epub 2014 Mar 15.

Authors

Alfonso Ielasi¹, Azeem Latib², Toru Naganuma², Bernardo Cortese³, Katsumasa Sato², Tadashi Miyazaki², Vasileios F Panoulas², Maurizio Tespili¹, Antonio Colombo⁴

Affiliations

¹ Cardiology Department, Bolognini Hospital, Seriate (BG), Italy.
² Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy; San Raffaele Scientific Institute, Milan, Italy.
³ Catetherization Laboratory, Fatebenefratelli Hospital, Milan, Italy.
⁴ Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy; San Raffaele Scientific Institute, Milan, Italy. Electronic address: [email protected].

PMID: 24717326
DOI: 10.1016/j.ijcard.2014.03.061

No abstract available

Keywords: Bioresorbable vascular scaffold; In-stent restenosis; Percutaneous coronary intervention.

Publication types

Letter
Comment

MeSH terms

Coronary Restenosis / therapy*
Drug-Eluting Stents*
Everolimus
Humans
Male
Sirolimus / administration & dosage
Sirolimus / analogs & derivatives*
Tissue Scaffolds*
Tomography, Optical Coherence*

Substances

Everolimus
Sirolimus